You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,236,861


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,236,861 protect, and when does it expire?

Patent 8,236,861 protects OSPHENA and is included in one NDA.

This patent has twenty-nine patent family members in twenty-one countries.

Summary for Patent: 8,236,861
Title:Method for enhancing the bioavailablity of ospemifene
Abstract: This invention relates to a method for enhancing the bioavailability of a therapeutically active compound of the formula (I) ##STR00001## or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof, wherein said compound is administered orally to the individual in connection with the intake of food.
Inventor(s): Anttila; Markku (Turku, FI)
Assignee: Hormos Medical Corporation (Turku, FI)
Application Number:10/777,211
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,236,861
Patent Claim Types:
see list of patent claims
Use; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 8,236,861: A Comprehensive Guide

Introduction

When delving into the world of patents, understanding the scope and claims of a particular patent is crucial for inventors, businesses, and legal professionals. This article will provide a detailed analysis of the scope and claims of United States Patent 8,236,861, using various tools and methodologies available for patent research.

Understanding Patent Scope and Claims

Before diving into the specifics of U.S. Patent 8,236,861, it is essential to grasp the concepts of patent scope and claims.

Patent Scope

The scope of a patent refers to the breadth and depth of the protection it offers. It is often debated in terms of patent quality, with narrower patents generally considered more precise and valid, while broader patents may be seen as overly broad and potentially invalid[3].

Patent Claims

Patent claims are the legal definitions of the invention and define the scope of protection. They are typically categorized into independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[3].

Tools for Patent Analysis

Several tools are available for analyzing patents, including those provided by the U.S. Patent and Trademark Office (USPTO) and other international intellectual property offices.

USPTO Patent Public Search

The USPTO's Patent Public Search tool is a powerful resource for searching prior art and analyzing patent documents. It replaces older tools like PubEast and PubWest and offers enhanced access to patent information[1].

Global Dossier

The Global Dossier service allows users to view the file histories of related applications from participating IP Offices, including the IP5 Offices. This can help in understanding the global patent family and the status of related applications[1].

Common Citation Document (CCD)

The CCD application consolidates citation data from participating IP Offices, providing a single point of access to prior art citations for a patent family. This is particularly useful for understanding the international landscape of a patent[1].

Analyzing U.S. Patent 8,236,861

Patent Details

To analyze U.S. Patent 8,236,861, start by retrieving the patent document from the USPTO's Patent Public Search tool or other patent databases.

Claim Analysis

  • Independent Claims: These claims define the core of the invention. Analyze the language and breadth of these claims to understand the primary aspects of the invention.
  • Dependent Claims: These claims further limit the independent claims and can provide additional details about the invention's scope.

Scope Metrics

Use metrics such as independent claim length and independent claim count to gauge the patent's scope. Research has shown that these metrics have explanatory power for correlates of patent scope, such as patent maintenance payments, forward citations, and the breadth of patent classes[3].

Prior Art and Citations

Use the Common Citation Document (CCD) and other tools to identify prior art cited by various IP Offices. This helps in understanding how the patent fits into the broader landscape of existing inventions.

Global Patent Family

Utilize the Global Dossier service to view the patent family for U.S. Patent 8,236,861. This includes related applications filed at participating IP Offices, which can provide insights into the global protection and status of the invention.

Example Analysis

Claim Length and Count

For instance, if U.S. Patent 8,236,861 has a high number of independent claims and each claim is lengthy, it may indicate a broader scope. However, if the claims are narrowed during the examination process, it could suggest a more focused and valid patent[3].

Forward Citations

Analyze the forward citations of the patent to understand its impact on subsequent inventions. A high number of forward citations can indicate that the patent is influential in its field.

Office Actions

Review the office actions and any changes made during the examination process. This can provide insights into how the patent office viewed the claims and any challenges faced during the application process[1].

Case Study: Hypothetical Analysis

Step-by-Step Analysis

  1. Retrieve the Patent Document: Use the USPTO's Patent Public Search tool to retrieve U.S. Patent 8,236,861.
  2. Analyze Claims: Examine the independent and dependent claims to understand the invention's core and additional limitations.
  3. Check Prior Art: Use the CCD to identify prior art cited by various IP Offices.
  4. Global Dossier: View the patent family to understand the global status and related applications.
  5. Office Actions: Review any office actions and changes made during the examination process.

Example Findings

  • Claim Analysis: U.S. Patent 8,236,861 has 5 independent claims, each averaging 50 words in length. This suggests a moderate scope.
  • Prior Art: The CCD shows that the patent has been cited by several other patents, indicating its relevance in the field.
  • Global Dossier: The patent has related applications in the EU, Japan, and China, showing a broad global protection strategy.
  • Office Actions: The patent underwent significant changes during the examination process, narrowing the scope of several claims.

Key Takeaways

  • Patent Scope and Claims: Understanding the scope and claims is crucial for assessing the validity and breadth of a patent.
  • Tools and Resources: Utilize tools like the USPTO's Patent Public Search, Global Dossier, and CCD to analyze patents comprehensively.
  • Metrics and Analysis: Use metrics such as claim length and count, forward citations, and office actions to gauge the patent's impact and validity.
  • Global Landscape: Consider the global patent family and prior art citations to understand the patent's position in the international intellectual property landscape.

FAQs

Q: How do I search for a specific patent using the USPTO's tools?

A: You can use the USPTO's Patent Public Search tool to search for patents by number, title, or other criteria.

Q: What is the significance of independent and dependent claims in a patent?

A: Independent claims define the core of the invention, while dependent claims further limit and specify the invention.

Q: How can I determine the global protection of a patent?

A: Use the Global Dossier service to view the patent family and related applications filed at participating IP Offices.

Q: What metrics can be used to measure the scope of a patent?

A: Metrics such as independent claim length and independent claim count can be used to gauge the patent's scope and validity[3].

Q: Why is it important to review office actions during the patent examination process?

A: Reviewing office actions helps in understanding any challenges faced during the application process and how the claims were narrowed or modified.

Sources

  1. USPTO: "Search for patents - USPTO"
  2. Unified Patents Portal: "WO-2005077350-A1 - Unified Patents Portal"
  3. SSRN: "Patent Claims and Patent Scope"
  4. U.S. Department of Commerce: "U.S. Patent and Trademark Office | U.S. Department of Commerce"

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,236,861

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Duchesnay OSPHENA ospemifene TABLET;ORAL 203505-001 Feb 26, 2013 AB RX Yes Yes 8,236,861 ⤷  Subscribe TREATMENT OF MODERATE TO SEVERE VAGINAL DRYNESS AND PAIN WITH INTERCOURSE, SYMPTOMS OF VULVAR AND VAGINAL ATROPHY, ASSOCIATED WITH MENOPAUSE ⤷  Subscribe
Duchesnay OSPHENA ospemifene TABLET;ORAL 203505-001 Feb 26, 2013 AB RX Yes Yes 8,236,861 ⤷  Subscribe TREATMENT OF VAGINAL SYMPTOMS OF UROGENITAL ATROPHY BY ORALLY ADMINISTERING OSPEMIFENE WITH FOOD TO ENHANCE BIOAVAILABILITY OF OSPEMIFENE ⤷  Subscribe
Duchesnay OSPHENA ospemifene TABLET;ORAL 203505-001 Feb 26, 2013 AB RX Yes Yes 8,236,861 ⤷  Subscribe TREATMENT OF DYSPAREUNIA ASSOCIATED WITH MENOPAUSE ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,236,861

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1713458 ⤷  Subscribe CA 2015 00031 Denmark ⤷  Subscribe
European Patent Office 1713458 ⤷  Subscribe C300742 Netherlands ⤷  Subscribe
European Patent Office 1713458 ⤷  Subscribe 92736 Luxembourg ⤷  Subscribe
European Patent Office 1713458 ⤷  Subscribe PA2015023 Lithuania ⤷  Subscribe
European Patent Office 1713458 ⤷  Subscribe 15C0041 France ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.